Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-03-08-Speech-2-247-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110308.22.2-247-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"In the light of the troubled process of managing the declared influenza A (H1N1) pandemic and the acknowledged numbers (2 900 deaths resulting from H1N1 influenza, whereas 40 000 were caused by seasonal influenza during the same year), the report calls for transparency, which seems laudable to us. This relates both to what happened – with the complete clarification of procedures adopted and responsibilities – and to the approach to future situations. The following issues are mentioned in particular: the question of the procurement of vaccines and anti-viral treatments; information on recorded cases and their severity; the granting of access to documents relating to clinical trials, research protocols and adverse effects of medicines (by the European Medicines Agency); and conflicts of interest among specialists who advise European public health authorities. The report ‘calls for the prevention plans established in the EU and its Member States for future influenza pandemics to be revised in order to gain in effectiveness and coherence, independence and flexibility’. It also recommends a strengthening of cooperation between Member States in this area, with regard to both the definition of the severity of viral outbreaks, and decision making. Overall, we consider it to be positive, and we voted in favour for this reason."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples